ClinicalTrials HQ

Bad Nauheim

Bad Nauheim

Bad Nauheim, Hesse, Germany

17 results · Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Left Bundle Branch Area Pacing (LBBAP) PMCF StudyArrhythmias, Cardiac, Bradycardia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, heart failureRecruitingNot applicable2026-09-25NCT07217392
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker SystemArrhythmias, Cardiac, Bradycardia, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrioventricular block, atrioventricular dissociation, cardiovascular disorder, heart disorderRecruitingNot applicable2026-09-24NCT07118358
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fractioncardiovascular disorder, heart disorder, heart failureRecruitingPhase 32026-09-24NCT06736574
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, interstitial lung disease, lung disorder, respiratory system disorder, skin disorder, systemic sclerosisActive, not recruitingPhase 22026-09-22NCT05270668
Association Between Biomarkers and Kidney Function Decline in Pulmonary HypertensionChronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, hypertensive disorder, kidney disorder, kidney failure, lung disorder, pulmonary hypertension, respiratory system disorder, urinary system disorder, vascular disorderRecruitingNot stated2026-09-08NCT06409624
LANDMARK Trial: a Randomised Controlled Trial of Myval THVVentricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorderRecruitingNot applicable2026-08-17NCT04275726
Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBCNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-08-07NCT07242352
NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinomaNot yet recruitingPhase 32026-08-05NCT07178730
PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFSNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, female breast carcinoma, neoplasm, skin disorderRecruitingNot stated2026-08-05NCT05792150
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of RecurrenceNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingNot stated2026-07-30NCT06830720
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef OutcomesArterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, hyperlipidemia, metabolic disease, vascular disorderActive, not recruitingPhase 32026-04-23NCT06008756
Sacituzumab Govitecan in Primary HER2-negative Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinomaActive, not recruitingPhase 32026-04-22NCT04595565
Decreasing Preoperative Stress to Prevent Postoperative Delirium and Postoperative Cognitive Decline in Cardiac Surgical Patients.Cognition Disorders, Cognitive Dysfunction, Confusion, Emergence Delirium, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Cognitive Complications, Postoperative Complications, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorderRecruitingNot applicable2026-02-17NCT05036538
International T1 Multicenter Outcome StudyArterial Occlusive Diseases, Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, arteriosclerosis disorder, cardiomyopathy, cardiovascular disorder, chronic renal failure syndrome, coronary artery disorder, heart disorder, heart failure, inflammatory disease, kidney disorder, kidney failure, myocardial ischemia, urinary system disorder, vascular disorderActive, not recruitingNot stated2026-01-06NCT03749343
Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow Haemodynamicschronic thromboembolic pulmonary hypertensionRecruitingNot stated2025-12-23NCT07299227
CMR-derived Quantitative Perfusion for Prediction of FFRChronic Coronary SyndromeNot yet recruitingNot stated2025-06-18NCT07018778
Prospective WCD Post CABG Registry (CABG Registry)cardiomyopathy, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorderRecruitingNot stated2024-11-04NCT06570902